Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Rituximab + Cyclophosphamide in Refractory Pemphigus
NCT01974518Phase 3Unknown
- Start
- Nov 2013
- Primary completion
- Jun 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in pemphigus. Status: unknown.
02
Drugs
rituximab
03
Conditions
pemphigus
Beyond the preview
Go deeper on NCT01974518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01974518.